The first patient has been dosed in a Phase 1 clinical trial that’s testing a gene therapy for people with recurring or treatment-resistant multiple…
Myeloma
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Latest news
Discussion
Dr. A is insisting that we should start treating my mother with a new myeloma medication right away. Dr. B is asking us to wait…
Discussion
When you become a caregiver, nobody warns you that you’ve also become: A Google Alert in human form, always staying up to date on…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to SAR446523, an investigational therapy being developed by Sanofi for people with…
Discussion
During my mom’s last support group meeting, the facilitator asked all the participants to introduce themselves and identify their cancer by name. One after the…
Johnson & Johnson‘s Darzalex (daratumumab) is now the first approved treatment for high-risk smoldering multiple myeloma (SMM) in the European Union (EU). SMM…
